flanders.bio member events

BCF Career Event

Are you orientating on the next steps in your career? Or are you an employer and wish to show job seekers what you have to offer? Join BCF Career Event on 14 November 2019 in Ghent ICC.

19 Nov 2019

Mini-symposium PET imaging: From tracer development to non-clinical and clinical applications

On the 19th of November, MIRaCLe (Molecular Imaging Research and Clinic Leuven) is hosting a mini-symposium in celebration of the installation of a new R&D PET tracer production lab and two new microPET cameras and one microCT camera (Molecubes).

21 Nov 2019

Digital Health Conference, the road from idea to patient

Healthcare is becoming more and more digital. Every day, new medical devices pop up. During this conference, we enlighten the full product lifecycle of medica devices: from idea to market.


29 Nov 2019

De Clercq & Partners annual ip seminar

De Clercq & Partners is happy to announce the programme of our yearly one-day patent seminar, an event that brings together cutting-edge topics and prominent figures from the industry to provide you with the latest developments in Intellectual Property.

2 Dec 2019


3 Dec 2019

Next-Generation Protein Analysis and Detection (3rd edition)

After two successful editions (organized in June 2015 & October 2017) featuring each time ~300 attendees, we are pleased to announce the 3rdedition that will take place in December 2019.

29 Jan 2020


30 Jan 2020

QM Conference 2020

Is there a future in Clinical and Pharmacovigilance Quality Management?

30 Jan 2020

Meet with Johnson & Johnson Innovation

In this event, representatives from Johnson & Johnson Innovation will provide an overview of goals and missions, highlighting how Johnson & Johnson Innovation interacts with the entrepreneurial community through JLABS, JJDC, The Innovation Centers and Janssen Business & Development.

22 Apr 2020

Are Randomized Clinical Trials Still Needed in 2020?

April 2020 will mark the 40th anniversary of Jay Herson’s paper “Patient Registration in a Cooperative Oncology Group”. That paper, published in the first volume of the journal Controlled Clinical Trials, dealt with sources of bias and randomization practices that existed at the time. Looking back, it is surprising to see how much has changed since 1980. Whilst randomization remains a key design feature for confirmatory trials aimed at new drug approval, many innoative non-randomized study designs have been proposed and used in recent years.